Learn how to read medication labels correctly to avoid dangerous mistakes. Understand dosage, directions, warnings, and storage for both prescription and OTC drugs to stay safe and get the most from your medicine.
Pharmacogenetic testing uses your DNA to predict how you'll respond to medications, preventing dangerous side effects before they happen. Studies show it cuts adverse drug reactions by 30%.
Authorized generics and first-to-file generics both cut drug costs, but authorized generics drive prices lower during the critical 180-day exclusivity window. Learn how they differ and how to get the best price.
Gemfibrozil lowers triglycerides but may weaken bones over time. Learn who's at risk, how it compares to other drugs, and what steps to take to protect your bone health while managing cholesterol.
Combining aspirin with blood thinners like warfarin, Eliquis, or Xarelto doubles your risk of dangerous bleeding. Learn who should avoid this mix, the signs of hidden bleeding, and safer alternatives.
Azilsartan medoxomil is an emerging option for pediatric hypertension, especially in kids with obesity or kidney issues. Learn how it works, its safety profile, dosing, and how it compares to other blood pressure meds for children.
Diltiazem helps with high blood pressure and angina, but it's not the only option. Learn how amlodipine, lisinopril, metoprolol, and verapamil compare in effectiveness, side effects, and cost - and which one might be better for you.
Pharmacists play a vital role in spotting and reporting adverse reactions to generic medications. Learn why their reports matter, how to report them, and how under-reporting puts patients at risk.
Learn how to use the FDA Orange Book to verify if a generic drug is therapeutically equivalent to its brand-name counterpart. Understand TE codes, AB ratings, and common pitfalls in generic substitution.
12 Nov
2025
Learn how generic drugs, prescription coupons, and prior authorizations impact your out-of-pocket medication costs-and what you can do right now to save money in 2025.